Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

EuPRAXIA Early Implementation Phase Project

Project description

Building Europe’s next-generation plasma accelerator facility

Particle accelerators are essential for scientific discovery and innovation, but conventional facilities are large, costly, and resource-intensive. The EU-funded EuPRAXIA is developing a new generation of compact plasma-based accelerators that will make advanced research more accessible while expanding scientific and industrial applications. During its early implementation phase, the project will establish the organisational, legal, financial, and governance foundations of this pan-European research infrastructure. It will also strengthen collaboration with industry, develop data management and outreach activities, and prepare the distributed facility for operation. Once operational, EuPRAXIA will support cutting-edge research in fields such as medical imaging, materials science, biomolecular research, and free-electron laser applications, reinforcing Europe’s leadership in advanced accelerator technologies.

Objective

EuPRAXIA is a distributed, compact, and cutting-edge accelerator facility based on plasma technology, and it was included in the 2021 update of the ESFRI Roadmap.
In its initial phase, the consortium—comprising European research institutes and industrial partners—will construct an electron-beam-driven plasma accelerator in the metropolitan area of Rome, hosted by INFN at Frascati National Laboratories. This initiative will bring technological innovation, opportunities for spin-off companies, advanced scientific applications, and a dynamic international user community to central Italy.
Recently, the EuPRAXIA Collaboration Board selected ELI-ERIC as the host institution for the second pillar of the facility, namely the Laser-Driven Pillar, which will complement and reinforce the distributed research infrastructure model.
The Early Implementation Phase will build upon the achievements of the Preparatory Phase Project, with a focus on organizational development. Its primary objective is to lay the foundation for establishing a new legal entity. Furthermore, it will define a comprehensive business and financial plan, as well as refine the governance structure of the facility.
Additional areas to be addressed include data management, collaboration with industry, and the further development and implementation of the outreach and dissemination strategy initiated during the Preparatory Phase. EuPRAXIA will serve users in ultra-fast science, e.g. on high-resolution medical imaging, deeply penetrating positron annihilation spectroscopy for materials and with Europe’s most southern free-electron laser (FEL). It will offer fascinating capabilities for research on biomolecules, viruses and microscopic processes. EuPRAXIA will thus be a transformative step in the development of ultra-compact accelerators and applications.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-INFRA-2025-01

See all projects funded under this call

Coordinator

ISTITUTO NAZIONALE DI FISICA NUCLEARE
Net EU contribution
€ 298 781,25
Address
Via Enrico Fermi 54
00044 Frascati
Italy
Region
Centro (IT) Lazio Roma
Activity type
Research Organisations
Links
Total cost
No data

Participants (17)

Partners (2)